Success Stories: Redefining Cancer Research Through Molecular Science: NAILG Achieves NIW Approval for Biomedical Expert

Client’s Testimonial:

“Sincerely appreciate the support and patience of Chen’s team. Thanks for their dedicated effort in assisting with my profile.”

On October 20^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Fellow in the field of Biomedical Science (Approval Notice).

General Field: Biomedical Science

Position at the Time of Case Filing: Research Fellow

Country of Origin: China

State of Residence at the Time of Filing: Michigan

Approval Notice Date: October 20^th, 2025

Processing Time: 1 year, 8 months, 28 days

Case Summary:

As a leading researcher in biomedical science, the petitioner has built a distinguished career dedicated to understanding the molecular mechanisms that drive cancer and other chronic diseases. His groundbreaking investigations into the pathology of pancreatic cancer have opened new avenues for improving diagnostic and therapeutic strategies in oncology. Through meticulous molecular and translational studies, his work continues to contribute to national efforts aimed at advancing precision medicine and improving patient outcomes. Recognizing the far-reaching impact and national importance of his research, North America Immigration Law Group (NAILG) successfully secured approval of his EB-2 NIW (National Interest Waiver) petition.

The petitioner’s research focuses on elucidating the molecular and pathological processes that underlie pancreatic cancer development. His studies bridge molecular biology and clinical research to identify biomarkers and therapeutic targets that can enhance the treatment and management of cancer. This endeavor addresses one of the most pressing public health challenges in the United States, given the high mortality rates and limited treatment options associated with pancreatic cancer. His research plays an essential role in supporting the country’s biomedical innovation goals by improving the understanding of complex disease mechanisms and facilitating more effective medical interventions.

Beyond his scientific discoveries, the petitioner has established himself as a respected scholar and peer reviewer. He has conducted at least 14 reviews for academic journals and served as a guest editor for a special issue, a recognition reserved for experts of high standing in their field. His research portfolio includes 12 peer-reviewed journal articles that have collectively garnered 294 citations. These achievements illustrate both his productivity and his influence on the scientific community.

As one expert observed, “Having made a number of major contributions to the unveiling of microRNA pharmacological targets in diabetes, it is readily apparent that [Client] has crystallized his position as a top-tier contributor to the field.”

Through NAILG’s comprehensive presentation of his achievements, the petitioner’s case clearly demonstrated that his continued research in the United States would advance both national scientific progress and public health objectives. His success in securing NIW approval stands as recognition of his exceptional contributions to biomedical science and his capacity to further innovations that directly benefit society.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.